The official publication of Turkish Society of Clinical Biochemistry
Aim: This study aimed to examine the effects of the NF-κβ inhibitor parthenolide, the anti-carcinogenic drug cisplatin and their combinations on the NF-κβ and MEK1/MEK2 expression levels and phosphorylation status in the human monocytic leukemia cell line (THP-1).
...Objective: Automated hematology analyzer flags may provide early warning signals for hematological malignancies. This study aimed to evaluate the diagnostic performance of Sysmex XN-1000 analyzer flags and to develop a multivariable prediction model for identifying active...
Objective: Confirmation of the clonality of B lymphocytes by flow cytometry analysis has an important role in the diagnosis of Chronic Lymphocytic Leukemia (CLL). In this retrospective study, we investigated which surface light chain pattern they showed as indicative of the...
Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.
Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.
Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.
Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.
All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.